Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaozheng Sanjie Formula (also known as Xiao Zheng San Jie Granules or XZSJ) is a traditional Chinese medicine (TCM) herbal formula developed by Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine. It is formulated specifically for the treatment of diabetic kidney disease (DKD) / diabetic nephropathy, particularly in patients presenting with the TCM syndrome of Qi deficiency and blood stasis. The formula consists of six key herbal ingredients: Astragali Radix, Eucommiae Cortex, Sargassum, Eupolyphaga, Rhei Radix et Rhizoma, and Smilacis Glabrae Rhizoma. Pharmacological studies suggest that Xiaozheng Sanjie Formula exerts protective effects on glomerular mesangial cells, reduces urinary protein and serum creatinine levels, and mitigates renal inflammation and fibrosis, potentially through the downstream inhibition of the TNF-alpha/NF-kB and SphK1/S1P signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaozheng Sanjie Formula.